Even if soft tissue tumours are very rare, leiomyosarcoma is the most common sarcoma of the vulva, representing 1% of vulvar malignancies [1, 2, 4]. It originates from the smooth muscle containing erector-pili muscle, blood vessels walls  and round muscle or dartos muscle of the recto-vaginal septum [4, 5]. The most frequent location is the upper-vagina  and it usually occurs in women between 40 and 50 years . Radiation therapy in the genital tract has been reported as a risk factor .
The most common clinical presentation is a painless and rapidly-growing submucosal mass in labia majora [1, 3, 4, 5]. Other symptoms are pain, pruritus or erythema . Any vulvar lump with unusual characteristics such as rapid growth or hard consistence in Bartholin´s gland area should be investigated carefully to avoid delay in diagnosis [1, 2, 4, 5].
Diagnosis is usually based on histopathological examination of excised lesions taking into account that cytology may suggest benignity. It requires at least 3 of the following characteristics: atypical cells, mostly large and hyper-chromatic cells forming whirling and bundles, high proliferation index, infiltrating margins and more than 5 cm in diameter [2, 4, 5].
MRI is the modality of choice to allow proper tumoral delineation, evaluation of the local extent of the disease and its relationship to adjacent structures, to aid in surgical planning and to reduce surgical morbidity. Imaging findings of vulvar leiomyosarcomas are variable, such as of leiomyosarcomas in other locations. The tumor is usually described as a heterogeneous and irregularly-shaped mass, with areas of high T2 signal, due to cystic necrosis and areas of high T1 signal, due to hemorrhage. It often depicts heterogeneous contrast enhancement and areas of restricted diffusion on diffusion-weighted imaging. High signal intensity is detected on STIR sequences, without areas of fat .
CT body scanning is necessary to exclude lymphatic and haematogenous spread of the tumor. However, leiomyosarcomas localized in the Bartholin's gland area are often less aggressive [1, 4].
Currently, surgery is the treatment of choice. The role of radiotherapy and chemotherapy remains uncertain [1, 2, 4].